What’s more, SPTBN2 was associated with poor prognosis in patients with colorectal cancer and was highly expressed in patients with distant metastasis, lymph node metastasis, and clinical advanced colorectal cancer, with statistically significant differences [8]. The gene discussed is SPTBN2; the disease is colorectal cancer.